Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by JMark80on Dec 11, 2019 12:14am

88 Views

Post# 30442420

RE:RE:RE:RE:RE:RE:RE:RE:4,3 million at 0,045 on the ask side = fake

STEPHENFISHER33 wrote: I'm a shareholder silly. Made lots of money over the years on all the pumps and dumps kly did. I got out around.10 cents for I saw where it was headed. Writing is on the wall . I kept a measly 10K shares. Now face all the negatives instead of running away scared. Be a true investor. Not just a pumper. Never invest with just your gut feelings

You're a loser, Penny.

Bullboard Posts

Fobi AI responds to cease trade order, filing delay “disappointing”